- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 17, 2019
Financial News
Cellestia plans Phase II for solid, blood cancers with $20M series B
BioCentury | Jun 19, 2019
Distillery Therapeutics
HAS2 and NOTCH1 identified as targets in liver fibrosis induced by hepatitis B, hepatitis C and NASH
BioCentury | Nov 30, 2018
Targets & Mechanisms
Revving up metabolism at ASH 2018
A dive into the ASH 2018 abstracts highlights cancer metabolism as a top focus
BioCentury | Jan 18, 2018
Translation in Brief
A notch for tankyrase
NYU paper identifies new cancer opportunities for tankyrase inhibitors
Items per page:
1 - 10 of 68